Scientific Reports (Jun 2022)

Single-cell transcriptional profiling reveals cellular and molecular divergence in human maternal–fetal interface

  • Quanlei Wang,
  • Jinlu Li,
  • Shengpeng Wang,
  • Qiuting Deng,
  • Yanru An,
  • Yanan Xing,
  • Xi Dai,
  • Zelong Li,
  • Qiwang Ma,
  • Kuixing Wang,
  • Chuanyu Liu,
  • Yue Yuan,
  • Guoyi Dong,
  • Tao Zhang,
  • Huanming Yang,
  • Yutao Du,
  • Yong Hou,
  • Weilin Ke,
  • Zhouchun Shang

DOI
https://doi.org/10.1038/s41598-022-14516-z
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 15

Abstract

Read online

Abstract Placenta plays essential role in successful pregnancy, as the most important organ connecting and interplaying between mother and fetus. However, the cellular characteristics and molecular interaction of cell populations within the fetomaternal interface is still poorly understood. Here, we surveyed the single-cell transcriptomic landscape of human full-term placenta and revealed the heterogeneity of cytotrophoblast cell (CTB) and stromal cell (STR) with the fetal/maternal origin consecutively localized from fetal section (FS), middle section (Mid_S) to maternal section (Mat_S) of maternal–fetal interface. Then, we highlighted a subpopulation of CTB, named trophoblast progenitor-like cells (TPLCs) existed in the full-term placenta and mainly distributed in Mid_S, with high expression of a pool of putative cell surface markers. Further, we revealed the putative key transcription factor PRDM6 that might promote the differentiation of endovascular extravillous trophoblast cells (enEVT) by inhibiting cell proliferation, and down-regulation of PRDM6 might lead to an abnormal enEVT differentiation process in PE. Together, our study offers important resources for better understanding of human placenta and stem cell-based therapy, and provides new insights on the study of tissue heterogeneity, the clinical prevention and control of PE as well as the maternal–fetal interface.